<div class="container">

<table style="width: 100%;"><tr>
<td>N.APPLE.plus</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>APPLE+ sample size computation</h2>

<h3>Description</h3>

<p>Perform the sample size calculation given the power and post-delay hazard ratio using the close-form
APPLE+ method based on the generalized piecewise weighted log-rank test when the treatment time-lag
effect is present and the lag duration varies heterogeneously from individual to individual
or from study to study, within a certain domain and following a specific pattern.                       
</p>


<h3>Usage</h3>

<pre><code class="language-R"> N.APPLE.plus(lambda1, tl, tu, HR, tao, A, beta, ap=0.5, alpha=0.05)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>lambda1</code></td>
<td>
<p>Baseline hazard</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>tl</code></td>
<td>
<p>Lower bound of delayed duration domain</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>tu</code></td>
<td>
<p>Upper bound of delayed duration domain</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>HR</code></td>
<td>
<p>Post-delay hazard ratio after <code>tu</code>, defined as the post-delay hazard rate of the treatment group compared to that of the control group</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>tao</code></td>
<td>
<p>Total study duration</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>A</code></td>
<td>
<p>Total enrollment duration</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>beta</code></td>
<td>
<p>Type II error rate; Power=1-beta</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ap</code></td>
<td>
<p>Experimental-control allocation ratio. The default is 0.5.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>
<p>Type I error rate (two-sided). The default is 0.05.</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>APPLE+ is an acronym for: <br>
Analytic Power calculation method based on generalized Piecewise weighted Log-rank tEst
with random treatment time-lag effect.
See the reference for details of this method. 
</p>


<h3>Value</h3>

<p> The sample size
</p>


<h3>Author(s)</h3>

<p>Zhenzhen Xu &lt;Zhenzhen.Xu@fda.hhs.gov&gt;, Boguang Zhen&lt;Boguang.Zhen@fda.hhs.gov&gt;,
Yongsoek Park &lt;yongpark@pitt.edu&gt; and Bin Zhu &lt;bin.zhu@nih.gov&gt;
</p>


<h3>References</h3>

<p>Xu, Z., Park, Y., Zhen, B. &amp; Zhu, B. (2017). 
Achieving optimal power of logrank test with random treatment time-lag effect. 
Biometrika. Under review. 
</p>
<p>Xu, Z., Zhen, B., Park, Y., &amp; Zhu, B. (2017). Designing therapeutic cancer vaccine trials with
delayed treatment effect. Statistics in medicine, 36(4), 592-605.
</p>


<h3>See Also</h3>

<p><code>pow.APPLE.plus</code>, <code>HR.APPLE.plus</code></p>


<h3>Examples</h3>

<pre><code class="language-R">  lambda1 &lt;- 0.001982
  tl      &lt;- 30
  tu      &lt;- 30*11
  HR      &lt;- 1.3
  tao     &lt;- 365*3
  A       &lt;- 365
  beta    &lt;- 0.2
  N.APPLE.plus(lambda1, tl, tu, HR, tao, A, beta)
</code></pre>


</div>